Treatment of Adult Acute Lymphoblastic Leukemia (ALL) With a Focus on ... Cancer Network [17] The prognostic role of CD20 expression in ALL is controversial; nonetheless, targeted therapies directed against this marker have been developed. Recent data from the MD Anderson Cancer Center have indicated that the addition of rituximab (Rituxan ... |
